• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BH3 仅蛋白 Bik 参与多发性骨髓瘤细胞的凋亡诱导和对氧化应激的敏感性。

BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.

机构信息

Institut de Recherche Thérapeutique de l'Université de Nantes, Equipe 10 labellisée Ligue Nationale contre le Cancer 2008, 8 quai Moncousu, Nantes BP70721 F-44007, France.

出版信息

Br J Cancer. 2010 Dec 7;103(12):1808-14. doi: 10.1038/sj.bjc.6605981. Epub 2010 Nov 9.

DOI:10.1038/sj.bjc.6605981
PMID:21063407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3008608/
Abstract

BACKGROUND

although gene expression profile of multiple myeloma (MM) patients shows a wide range of Bik/Nbk expression, varying from absent to high, its regulation and function in myeloma cells is poorly understood. Thus, we addressed these questions in MM.

METHODS

human myeloma cell lines (HMCLs) and primary purified myeloma cells were studied for Bcl-2 family protein expression by western blot and further correlation analysis was performed. Correlative study between Bik and thyrotroph embryonic factor (TEF) transcription factor expression was analysed by PCR. Stress oxidative response was analysed by flow cytometry.

RESULTS

a strong expression of Bik protein was found only in one out of three of HMCL and correlated to Bcl-2 expression (P=0.0006). We demonstrated that Bik could be regulated at the protein level by Bcl-2 and at the transcriptional level by TEF. Bik overexpression sensitises myeloma cells to oxidative stress whereas Bik silencing increases resistance to H(2)O(2) oxidative stress. Furthermore, Bik ectopic expression disrupts Bim/Bcl-2 and Bim/Bcl-xL endogenous complexes triggering Bim release that could induce Bax and Bak activation.

CONCLUSIONS

ours results suggest that Bik has a role in both, apoptosis induction and sensitivity to oxidative stress in myeloma cells. Small BH3 mimetic molecules should be considered for further apoptosis-based therapy in myeloma cells expressing endogenous Bik/Bcl-2 complexes.

摘要

背景

尽管多发性骨髓瘤(MM)患者的基因表达谱显示 Bik/Nbk 表达范围广泛,从缺失到高表达不等,但它在骨髓瘤细胞中的调节和功能仍知之甚少。因此,我们在 MM 中研究了这些问题。

方法

通过 Western blot 研究了人骨髓瘤细胞系(HMCL)和原代纯化骨髓瘤细胞中 Bcl-2 家族蛋白的表达,并进行了进一步的相关性分析。通过 PCR 分析了 Bik 和甲状腺激素胚胎因子(TEF)转录因子表达之间的相关性。通过流式细胞术分析应激氧化反应。

结果

只有在 3 个 HMCL 中的 1 个中发现 Bik 蛋白表达强烈,与 Bcl-2 表达相关(P=0.0006)。我们证明 Bik 可以在蛋白水平上被 Bcl-2 调节,在转录水平上被 TEF 调节。Bik 的过表达使骨髓瘤细胞对氧化应激敏感,而 Bik 沉默增加了对 H2O2 氧化应激的抵抗力。此外,Bik 异位表达破坏了 Bim/Bcl-2 和 Bim/Bcl-xL 内源性复合物,引发 Bim 释放,从而诱导 Bax 和 Bak 的激活。

结论

我们的结果表明,Bik 在骨髓瘤细胞的凋亡诱导和对氧化应激的敏感性中都发挥作用。在表达内源性 Bik/Bcl-2 复合物的骨髓瘤细胞中,应考虑使用小分子 BH3 模拟物进行进一步的基于凋亡的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/0210aafa4774/6605981f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/8b733a71fc7b/6605981f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/ba6ffec42e59/6605981f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/972cdd451fed/6605981f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/3abd7a2403e3/6605981f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/0210aafa4774/6605981f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/8b733a71fc7b/6605981f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/ba6ffec42e59/6605981f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/972cdd451fed/6605981f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/3abd7a2403e3/6605981f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca4/3008608/0210aafa4774/6605981f5.jpg

相似文献

1
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.BH3 仅蛋白 Bik 参与多发性骨髓瘤细胞的凋亡诱导和对氧化应激的敏感性。
Br J Cancer. 2010 Dec 7;103(12):1808-14. doi: 10.1038/sj.bjc.6605981. Epub 2010 Nov 9.
2
BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death.仅含BH3结构域的BIK在应激诱导的细胞死亡过程中调节BAX、BAK依赖的内质网钙库Ca2+释放及线粒体凋亡。
J Biol Chem. 2005 Jun 24;280(25):23829-36. doi: 10.1074/jbc.M500800200. Epub 2005 Apr 4.
3
PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.PAR bZIP-bik是一种新型转录途径,可介导成纤维细胞中氧化应激诱导的细胞凋亡。
Cell Death Differ. 2009 Jun;16(6):838-46. doi: 10.1038/cdd.2009.13. Epub 2009 Feb 13.
4
The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.蛋白酶体抑制剂硼替佐米通过仅含BH3结构域的蛋白Bik和Bim使细胞对死亡受体配体TRAIL诱导的杀伤作用敏感。
Mol Cancer Ther. 2005 Mar;4(3):443-9. doi: 10.1158/1535-7163.MCT-04-0260.
5
Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.BIK/NBK在E1A和p53凋亡信号作用下的诱导及内质网定位
Oncogene. 2002 Apr 11;21(16):2534-44. doi: 10.1038/sj.onc.1205340.
6
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.在结肠癌细胞中通过同时诱导Noxa/Bik和拮抗Bcl-2/Bcl-xL逆转突变型KRAS介导的凋亡抗性
Mol Cancer Res. 2015 Apr;13(4):659-69. doi: 10.1158/1541-7786.MCR-14-0476. Epub 2014 Dec 29.
7
NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.NBK/BIK可拮抗MCL-1和BCL-XL,并在蛋白质合成抑制时激活BAK介导的细胞凋亡。
Genes Dev. 2007 Apr 15;21(8):929-41. doi: 10.1101/gad.1522007. Epub 2007 Apr 2.
8
The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.促凋亡的Bcl-2同源物Bak和Nbk/Bik克服了Mdr-1阴性和Mdr-1过表达乳腺癌细胞系中的耐药性。
Oncogene. 2002 Jan 10;21(2):227-38. doi: 10.1038/sj.onc.1205010.
9
Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.Bik/NBK的积累与硼替佐米(PS-341,万珂)及其他蛋白酶体抑制剂诱导的细胞凋亡相关。
Oncogene. 2005 Jul 21;24(31):4993-9. doi: 10.1038/sj.onc.1208683.
10
Concomitant loss of proapoptotic BH3-only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.促凋亡的仅含BH3结构域的Bcl-2拮抗剂Bik和Bim的同时缺失会阻止精子发生。
EMBO J. 2005 Nov 16;24(22):3963-73. doi: 10.1038/sj.emboj.7600857. Epub 2005 Nov 3.

引用本文的文献

1
A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.癌症治疗的新时代:靶向蛋白酶体 - Bcl - 2轴。
J Exp Clin Cancer Res. 2025 Aug 21;44(1):246. doi: 10.1186/s13046-025-03505-5.
2
Mitochondrial dysfunction and drug targets in multiple myeloma.线粒体功能障碍与多发性骨髓瘤的药物靶点。
J Cancer Res Clin Oncol. 2023 Aug;149(10):8007-8016. doi: 10.1007/s00432-023-04672-8. Epub 2023 Mar 16.
3
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.AT-101增强来那度胺对多发性骨髓瘤患者的抗肿瘤活性。

本文引用的文献

1
Bz-423 superoxide signals B cell apoptosis via Mcl-1, Bak, and Bax.Bz-423超氧化物通过Mcl-1、Bak和Bax发出B细胞凋亡信号。
Biochem Pharmacol. 2009 Oct 15;78(8):966-73. doi: 10.1016/j.bcp.2009.05.025. Epub 2009 May 27.
2
PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts.PAR bZIP-bik是一种新型转录途径,可介导成纤维细胞中氧化应激诱导的细胞凋亡。
Cell Death Differ. 2009 Jun;16(6):838-46. doi: 10.1038/cdd.2009.13. Epub 2009 Feb 13.
3
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings.
Cancers (Basel). 2023 Jan 12;15(2):477. doi: 10.3390/cancers15020477.
4
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.BIK 通过亚致死性细胞凋亡驱动侵袭性乳腺癌表型,并预测 ER 阳性乳腺癌的不良预后。
Cell Death Dis. 2020 Jun 11;11(6):448. doi: 10.1038/s41419-020-2654-2.
5
Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.伴有 1q21 扩增的多发性骨髓瘤对 MCL-1 靶向治疗高度敏感。
Blood Adv. 2019 Dec 23;3(24):4202-4214. doi: 10.1182/bloodadvances.2019000702.
6
Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient.维奈托克联合卡非佐米、阿霉素和地塞米松可恢复一名原本治疗难治性多发性骨髓瘤患者的反应性。
Haematologica. 2020 Mar;105(3):e138-e140. doi: 10.3324/haematol.2019.232330. Epub 2019 Aug 29.
7
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.靶向治疗慢性淋巴细胞白血病和其他血液系统恶性肿瘤中的 BCL2。
Drugs. 2019 Aug;79(12):1287-1304. doi: 10.1007/s40265-019-01163-4.
8
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma.抗凋亡BCL-2蛋白在多发性骨髓瘤中的作用与调控
Front Oncol. 2018 Nov 20;8:533. doi: 10.3389/fonc.2018.00533. eCollection 2018.
9
Administration of follicle-stimulating hormone induces autophagy via upregulation of HIF-1α in mouse granulosa cells.促卵泡激素给药通过上调小鼠颗粒细胞中的低氧诱导因子-1α诱导自噬。
Cell Death Dis. 2017 Aug 17;8(8):e3001. doi: 10.1038/cddis.2017.371.
10
Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.双相活性氧生成、p53和BIK决定了结肠癌细胞对DNA损伤的细胞死亡模式。
PLoS One. 2017 Aug 10;12(8):e0182809. doi: 10.1371/journal.pone.0182809. eCollection 2017.
多发性骨髓瘤的新药:作用机制及I/II期临床研究结果
Lancet Oncol. 2008 Dec;9(12):1157-65. doi: 10.1016/S1470-2045(08)70304-8.
4
Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.髓细胞白血病序列1(Mcl-1)决定了Nbk/Bik诱导的细胞凋亡对Bax的依赖性。
J Cell Biol. 2007 Nov 19;179(4):701-15. doi: 10.1083/jcb.200703040.
5
Bim and Bcl-2 mutually affect the expression of the other in T cells.Bim和Bcl-2在T细胞中相互影响对方的表达。
J Immunol. 2007 Sep 15;179(6):3417-24. doi: 10.4049/jimmunol.179.6.3417.
6
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.BH3分析可识别出三类不同的凋亡阻滞情况,以预测对ABT-737和传统化疗药物的反应。
Cancer Cell. 2007 Aug;12(2):171-85. doi: 10.1016/j.ccr.2007.07.001.
7
Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation.Mcl-1和Bim免受泛素-蛋白酶体降解的相互保护作用。
Biochem Biophys Res Commun. 2007 Oct 5;361(4):865-9. doi: 10.1016/j.bbrc.2007.07.070. Epub 2007 Jul 24.
8
The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.正常、反应性和恶性浆细胞的表型。“多发性骨髓瘤”的鉴定及骨髓瘤治疗新靶点
Haematologica. 2006 Sep;91(9):1234-40.
9
The molecular classification of multiple myeloma.多发性骨髓瘤的分子分类
Blood. 2006 Sep 15;108(6):2020-8. doi: 10.1182/blood-2005-11-013458. Epub 2006 May 25.
10
Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.组织特异性促凋亡仅含BH3结构域蛋白Nbk/Bik的缺失是肾细胞癌的一个共同特征。
Cell Death Differ. 2006 Apr;13(4):619-27. doi: 10.1038/sj.cdd.4401782.